Suchergebnisse

Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, as the Generic Drug Act that have enhanced access to essential medicines while lowering drug costs. In contrast with analysis of pharmaceutical regulation that invokes international guidelines as inspiration for countries to reformulate their norms or argues that regulations emerge in order to serve the interests of powerful interest groups; this paper focuses on actors' preferences and demands to explain how Brazil promoted this large-scale regulatory policy. Paradoxically, the generic drug regulation introduced in the name of patients and opposed by local firms given the high cost to adapt its plants and processes, is today opposed by important patient advocacy groups but solidified by the strong support of local and multinational pharmaceutical firms. The paper concludes that the state still matters for pharmaceutical regulation and that pharmaceutical regulation is only partially influenced by non-state actors.

This article sheds new light on the drivers of bureaucratic resilience in the face of presidential attacks, an understudied but politically salient topic. Scholars have long shown how political advocacy can protect bureaucracies from presidential attacks on policy regulation. We argue, however, that advocacy is insufficient to defend bureaucracies against attacks on policy implementation, which occurs largely outside the formal political arena. Through a case study of Brazil's successful Covid-19 vaccination campaign, we call attention to two additional forms of support for agencies under attack—resource provision and social activism—that come into play during the implementation phase of policy. In conjunction with political advocacy, resource provision and social activism bolster bureaucracies under attack by filling in where other forms of support fall short.

AbstractBrazil has encouraged an ambitious set of policies towards the pharmaceutical industry, aiming to foster technological development while meeting health requirements. We characterise these efforts, labelled the 'Complexo Industrial da Saúde' (Health-Industry Complex, CIS), as an outcome of incremental policy change backed by the sustained efforts of public health professionals within the federal bureaucracy. As experts with a particular vision of the relationship between health, innovation and industry came to dominate key institutions, they increasingly shaped government responses to emerging challenges. Step by step, these professionals first made science and technology essential aspects of Brazil's health policy, and then merged the Ministry of Health's new focus on science, technology and health with industrial policy measures aimed at private firms. We contrast our depiction of these policy changes with a conventional view that relies on a partisan orientation of the executive.

What effects do interest groups have on the democratization and legitimacy of the European Union (EU)? Interest groups can democratize the EU only to the extent that they do not replicate inequalities. We use a newly constructed database to look for inequalities: Are the big organizations in Brussels the same as the ones in the EU member states? Are some member states' lobbies more active than others? And does the structure of EU lobbying create insiders and outsiders itself? We find representative biases in favor of powerful incumbents, groups from some member states and wellresourced groups.

Policy analysis in Brazil is part of the International Library of Policy Analysis and is the first book to paint a comprehensive panorama of policy analysis activities in Brazil. Highlighting the unique features of the Brazilian example, it brings together 18 studies by leading Brazilian social scientists on policy analysis as a widespread activity pursued in a variety of policy fields and through different methods by governmental and non-governmental institutions and actors. It shows how policy analysis emerged as part of Brazilian state-building from the 1930s onwards. With the democratisation process of the late 1980s, policy analysis began to include innovative elements of social participation in public management. This unique book offers key insights into the practice of this field and is indispensable reading for scholars, policy makers and students of the social sciences interested in learning how policy analysis developed and functions in Brazil